Sign in

CIK 0001376339

  • Large accelerated filer

MIMEDX GROUP, INC.

Sign in to watch
Ticker
MDXG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
EIN
262792552
Phone
+1 770-651-9100
Business address
1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
Former names
Alynx, Co.
  1. 4 Open-market sale General Counsel and CAO sold 11,308 shares at $4.24 ($47,998)
  2. 4 Open-market sale Chief Financial Officer sold 19,000 shares at $4.50 ($85,416)
  3. 4 Open-market sale General Counsel and CAO sold 15,555 shares at $4.53 ($70,477)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market sale Chief Financial Officer sold 4,992 shares at $2.82 ($14,053)
  7. 4 Grant or award Interim CEO acquired 200,000 shares (grant or award)
  8. 4 Open-market sale President, Regenerative Med. sold 27,329 shares at an average $3.44 ($94,069)
  9. 4 Open-market sale President, Regenerative Med. sold 8,503 shares at $4.04 ($34,344)
  10. 4 Open-market sale President, WC & Surgical sold 12,343 shares at $4.21 ($51,939)
  11. 4 Open-market sale President, Regenerative Med. sold 19,500 shares at $3.62 ($70,590)
  12. 4 Open-market sale President, Regenerative Med. sold 14,600 shares at $3.47 ($50,662)
  13. 4 Open-market sale Chief Executive Officer sold 112,000 shares at $3.75 ($420,000)
  14. 4 Grant or award Director acquired 44,191 shares (grant or award)
  15. 4 Grant or award Director acquired 44,191 shares (grant or award)
  16. 4 Grant or award Director acquired 44,191 shares (grant or award)
  17. 4 Grant or award Director acquired 44,191 shares (grant or award)
  18. 4 Grant or award Director acquired 44,191 shares (grant or award)
  19. 4 Grant or award Director acquired 44,191 shares (grant or award)
  20. 4 Grant or award Director acquired 44,191 shares (grant or award)

Page 6 of 30 · 584 filings